Averting Opioid-induced Respiratory Depression without Affecting Analgesia
The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
The ventilatory control system is highly vulnerable to exogenous administered opioid analgesics. Particularly respiratory depression is a potentially lethal complication that may occur when opioids are overdosed or consumed in combination with other depressants such as sleep medication or alcohol. Fatalities occur in acute and chronic pain patients on opioid therapy and individuals that abuse prescription or illicit opioids for their hedonistic pleasure. One important strategy to mitigate opioid-induced respiratory depression is cotreatment with nonopioid respiratory stimulants. Effective stimulants prevent respiratory depression without affecting the analgesic opioid response. Several pharmaceutical classes of nonopioid respiratory stimulants are currently under investigation. The majority acts at sites within the brainstem respiratory network including drugs that act at α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (ampakines), 5-hydroxytryptamine receptor agonists, phospodiesterase-4 inhibitors, D 1 -dopamine receptor agonists, the endogenous peptide glycyl-glutamine, and thyrotropin-releasing hormone. Others act peripherally at potassium channels expressed on oxygen-sensing cells of the carotid bodies, such as doxapram and GAL021 (Galleon Pharmaceuticals Corp., USA). In this review we critically appraise the efficacy of these agents. We conclude that none of the experimental drugs are adequate for therapeutic use in opioid-induced respiratory depression and all need further study of efficacy and toxicity. All discussed drugs, however, do highlight potential mechanisms of action and possible templates for further study and development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Pre-Bötzinger Complex: a Brainstem Region that May Generate Respiratory Rhythm in Mammals
Smith, J. C., Ellenberger, H. H., Ballanyi, K., Richter, D. W., & Feldman, J. L. (1991) · Science · doi:10.1126/science.1683005 · Cited by 2,175
Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies
Volkow, N. D., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507771 · Cited by 1,305
Long-Term Effects of Caffeine Therapy for Apnea of Prematurity
Schmidt, B., Roberts, R. S., Davis, P., Doyle, L. W., Barrington, K. J., Ohlsson, A., Solimano, A., & Tin, W. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073679 · Cited by 948
Structure-based discovery of opioid analgesics with reduced side effects
Manglik, A., Lin, H., Aryal, D. K., McCorvy, J. D., Dengler, D., Corder, G., Levit, A., Kling, R. C., Bernat, V., Hübner, H., et al. (2016) · Nature · doi:10.1038/nature19112 · Cited by 944
Opioids and the control of respiration
Pattinson, K. T. S. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen094 · Cited by 793
Incidence, reversal, and prevention of opioid-induced respiratory depression
Dahan, A., Aarts, L., & Smith, T. W. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181c38c25 · Cited by 634 · cited 3×
“We discuss the following K+-channel blockers with proven efficacy in reversal of opioid-induced respiratory depression: (1) almitrine, (2) doxapram, and (3) GAL021 (Galleon Pharmaceuticals Corp.”
BackgroundSelf-citationRekling, J. C., & Feldman, J. L. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.385 · Cited by 583
Bias factor and therapeutic window correlate to predict safer opioid analgesics
Schmid, C. L., Kennedy, N. M., Ross, N. C., Lovell, K. M., Yue, Z., Morgenweck, J., Cameron, M. D., Bannister, T. D., & Bohn, L. M. (2017) · Cell · doi:10.1016/j.cell.2017.10.035 · Cited by 567
McDonald, R., & Strang, J. (2016) · Addiction · doi:10.1111/add.13326 · Cited by 471
Buckler, K. J., Williams, B. A., & Honore, E. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00135.x · Cited by 428
Research works printed but not linked: 6
- 2013, Pharmacovigilance: A systematic review on opioid-induced respiratory depression (OIRD) in chronic pain patients., Pain Physician, 16, E85
- 2010, Naloxone reversal of morphine- and morphine-6-glucuronide-Induced respiratory depression in humans., Anesthesiology, 212, 1417
- 2000, Effects of neuroactive substances on the morphine-induced respiratory depression: An in vitro study., Brain Res, 884, 201
- 1974, Effects ventilatoires chez l’homme sain d’un nouvel analeptique respiratoire, le S2620., Bull Eur Physiopathol Respir, 10, 775
- 1983, Increased respiratory chemosensitivity in patients with chronic airways obstruction., Br J Dis Chest, 77, 136
- 1962, A new centrally acting agent (AHR-619) with marked respiratory stimulating, pressor, and “awakening” effects., Fed Proc, 21, 325
Cited by
The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies
Han, Y., Yan, W., Zheng, Y., Khan, M. Z., Yuan, K., & Lu, L. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0625-0 · Cited by 239
Gudin, J., & Fudin, J. (2020) · Pain and Therapy · doi:10.1007/s40122-019-00143-6 · Cited by 172
Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain
Reeves, K. C., Shah, N., Muñoz, B., & Atwood, B. K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.919773 · Cited by 156
Algera, M. H., Kamp, J., van der Schrier, R., van Velzen, M., Niesters, M., Aarts, L., Dahan, A., & Olofsen, E. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.12.023 · Cited by 123
Self-citationAyad, S. S., Khanna, A. K., Iqbal, S. U., & Singla, N. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.05.044 · Cited by 112
Metadata
- Authors
- Dahan, A., van der Schrier, R., Smith, T., Aarts, L., van Velzen, M., & Niesters, M.
- Affiliations
- Leiden University Medical Center (NL)
- From the Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands.
- Corresponding author
- Dahan, Albert
- Venue
- Anesthesiology
- Published
- 2018-05
- Volume
- 128
- Issue
- 5
- Pages
- 1027-1037
- ISSN
- 0003-3022 (ISSN-L)
- OpenAlex
- W2794081746
- Semantic Scholar
- 441a08a837b1787663801ebcded3979a6542ba04
- Cited by
- 115
- References
- 122
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 11 · 2023: 17 · 2022: 19 · 2021: 24 · 2020: 17 · 2019: 9
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Anesthesiology (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroscience of respiration and sleep
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- opioid-induced respiratory depression, ventilation control, brainstem respiratory network, AMPA receptor agonists, serotonin receptor agonists, phosphodiesterase-4 inhibitors, dopamine D1 receptor agonist, thyrotropin-releasing hormone, doxapram, opioid analgesia, opioid overdose
- MeSH terms
- Analgesia, Analgesics, Opioid, Animals, Carotid Body, Dipeptides, Humans, Respiratory Insufficiency, Receptors, Dopamine D1, Respiratory System Agents, Phosphodiesterase 4 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Averting Opioid-induced Respiratory Depression without Affecting Analgesia. https://app.cochat.ai/papers/10.1097/aln.0000000000002184
- The paper
- Dahan, A., van der Schrier, R., Smith, T., Aarts, L., van Velzen, M., & Niesters, M. (2018). Averting Opioid-induced Respiratory Depression without Affecting Analgesia. Anesthesiology. https://doi.org/10.1097/aln.0000000000002184
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.